Hepcinat Plus (Sofosbuvir 400mg + Daclatasvir 60mg)
Manufacturer: Natco Pharma Ltd.
Form: Tablets (28 tablets per bottle)
Hepcinat Plus is a combination antiviral medication developed by Natco Pharma for the treatment of chronic Hepatitis C Virus (HCV) infection.
Each tablet contains Sofosbuvir (400 mg) and Daclatasvir (60 mg) — two highly effective direct-acting antiviral agents (DAAs) that work together to stop the virus from multiplying in the body.
This combination therapy helps reduce the viral load and can completely clear the infection after a full treatment course, depending on the patient’s genotype and liver condition.
Do not stop treatment without consulting your physician.
Most patients tolerate Hepcinat Plus well, but some may experience:
If any severe reactions occur, seek medical advice immediately.
Ask a question or inquire about delivery to your country


